Antineoplastic Drugs Market Report

Global and Region Antineoplastic Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：174
  • REPORT CODE：GMM1012313
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Antineoplastic Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Antineoplastic Drugsmarket, defines the market attractiveness level of Antineoplastic Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Antineoplastic Drugs industry, describes the types of Antineoplastic Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antineoplastic Drugs market and the development prospects and opportunities of Antineoplastic Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antineoplastic Drugs market in Chapter 13.

    By Player:

    • Merc & Co

    • Accord Healthcare

    • Baxter Healthcare

    • Lundbeck

    • Bristol-Myers Squibb

    • AbbVie

    • Bayer AG

    • Johnson & Johnson

    • Boehringer Ingelheim

    • Genentech

    • Amgen

    • Teva pharmaceutical Industries

    • Aspen Global

    • Hoffmann-La Roche

    • Pfize

    By Type:

    • Chemotherapeutic Agents

    • Biological/Immunotherapeutic Agents

    • Personalized Medicine

    By End-User:

    • Hospitals

    • Clinics

    • Cancer Rehabilitation Centers

    • Ambulatory Surgical Centers

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Antineoplastic Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Antineoplastic Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Antineoplastic Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Antineoplastic Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Antineoplastic Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Antineoplastic Drugs Consumption (2017-2022)

    • 7.2 United States Antineoplastic Drugs Consumption (2017-2022)

    • 7.3 Europe Antineoplastic Drugs Consumption (2017-2022)

    • 7.4 China Antineoplastic Drugs Consumption (2017-2022)

    • 7.5 Japan Antineoplastic Drugs Consumption (2017-2022)

    • 7.6 India Antineoplastic Drugs Consumption (2017-2022)

    • 7.7 South Korea Antineoplastic Drugs Consumption (2017-2022)

    8 Region and Country-wise Antineoplastic Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Antineoplastic Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Antineoplastic Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Antineoplastic Drugs Consumption Forecast (2022-2028)

    • 8.4 China Antineoplastic Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Antineoplastic Drugs Consumption Forecast (2022-2028)

    • 8.6 India Antineoplastic Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Antineoplastic Drugs Consumption Forecast (2022-2028)

    9 Global Antineoplastic Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Antineoplastic Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Chemotherapeutic Agents Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Biological/Immunotherapeutic Agents Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Personalized Medicine Consumption and Growth Rate (2017-2022)

    • 9.2 Global Antineoplastic Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cancer Rehabilitation Centers Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    10 Global Antineoplastic Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Antineoplastic Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Chemotherapeutic Agents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Biological/Immunotherapeutic Agents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Antineoplastic Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cancer Rehabilitation Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    11 Global Antineoplastic Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Antineoplastic Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Antineoplastic Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Antineoplastic Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Antineoplastic Drugs Market Competitive Analysis

    • 14.1 Merc & Co

      • 14.1.1 Merc & Co Company Details

      • 14.1.2 Merc & Co Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Merc & Co Antineoplastic Drugs Product and Service

    • 14.2 Accord Healthcare

      • 14.2.1 Accord Healthcare Company Details

      • 14.2.2 Accord Healthcare Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Accord Healthcare Antineoplastic Drugs Product and Service

    • 14.3 Baxter Healthcare

      • 14.3.1 Baxter Healthcare Company Details

      • 14.3.2 Baxter Healthcare Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Baxter Healthcare Antineoplastic Drugs Product and Service

    • 14.4 Lundbeck

      • 14.4.1 Lundbeck Company Details

      • 14.4.2 Lundbeck Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Lundbeck Antineoplastic Drugs Product and Service

    • 14.5 Bristol-Myers Squibb

      • 14.5.1 Bristol-Myers Squibb Company Details

      • 14.5.2 Bristol-Myers Squibb Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bristol-Myers Squibb Antineoplastic Drugs Product and Service

    • 14.6 AbbVie

      • 14.6.1 AbbVie Company Details

      • 14.6.2 AbbVie Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AbbVie Antineoplastic Drugs Product and Service

    • 14.7 Bayer AG

      • 14.7.1 Bayer AG Company Details

      • 14.7.2 Bayer AG Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bayer AG Antineoplastic Drugs Product and Service

    • 14.8 Johnson & Johnson

      • 14.8.1 Johnson & Johnson Company Details

      • 14.8.2 Johnson & Johnson Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Johnson & Johnson Antineoplastic Drugs Product and Service

    • 14.9 Boehringer Ingelheim

      • 14.9.1 Boehringer Ingelheim Company Details

      • 14.9.2 Boehringer Ingelheim Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Boehringer Ingelheim Antineoplastic Drugs Product and Service

    • 14.10 Genentech

      • 14.10.1 Genentech Company Details

      • 14.10.2 Genentech Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Genentech Antineoplastic Drugs Product and Service

    • 14.11 Amgen

      • 14.11.1 Amgen Company Details

      • 14.11.2 Amgen Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Amgen Antineoplastic Drugs Product and Service

    • 14.12 Teva pharmaceutical Industries

      • 14.12.1 Teva pharmaceutical Industries Company Details

      • 14.12.2 Teva pharmaceutical Industries Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Teva pharmaceutical Industries Antineoplastic Drugs Product and Service

    • 14.13 Aspen Global

      • 14.13.1 Aspen Global Company Details

      • 14.13.2 Aspen Global Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Aspen Global Antineoplastic Drugs Product and Service

    • 14.14 Hoffmann-La Roche

      • 14.14.1 Hoffmann-La Roche Company Details

      • 14.14.2 Hoffmann-La Roche Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Hoffmann-La Roche Antineoplastic Drugs Product and Service

    • 14.15 Pfize

      • 14.15.1 Pfize Company Details

      • 14.15.2 Pfize Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Pfize Antineoplastic Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Antineoplastic Drugs

    • Figure Antineoplastic Drugs Picture

    • Table Global Antineoplastic Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Antineoplastic Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Antineoplastic Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Antineoplastic Drugs Consumption by Country (2017-2022)

    • Figure United States Antineoplastic Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Antineoplastic Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Antineoplastic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Antineoplastic Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Antineoplastic Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Antineoplastic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Antineoplastic Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Antineoplastic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Antineoplastic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Antineoplastic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Antineoplastic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Antineoplastic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Antineoplastic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapeutic Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Biological/Immunotherapeutic Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Personalized Medicine Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Rehabilitation Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapeutic Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biological/Immunotherapeutic Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Rehabilitation Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Antineoplastic Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Antineoplastic Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Merc & Co (Foundation Year, Company Profile and etc.)

    • Table Merc & Co Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merc & Co Antineoplastic Drugs Product and Service

    • Table Accord Healthcare (Foundation Year, Company Profile and etc.)

    • Table Accord Healthcare Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Accord Healthcare Antineoplastic Drugs Product and Service

    • Table Baxter Healthcare (Foundation Year, Company Profile and etc.)

    • Table Baxter Healthcare Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Healthcare Antineoplastic Drugs Product and Service

    • Table Lundbeck (Foundation Year, Company Profile and etc.)

    • Table Lundbeck Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lundbeck Antineoplastic Drugs Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Antineoplastic Drugs Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Antineoplastic Drugs Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Antineoplastic Drugs Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Antineoplastic Drugs Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Antineoplastic Drugs Product and Service

    • Table Genentech (Foundation Year, Company Profile and etc.)

    • Table Genentech Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Antineoplastic Drugs Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Antineoplastic Drugs Product and Service

    • Table Teva pharmaceutical Industries (Foundation Year, Company Profile and etc.)

    • Table Teva pharmaceutical Industries Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva pharmaceutical Industries Antineoplastic Drugs Product and Service

    • Table Aspen Global (Foundation Year, Company Profile and etc.)

    • Table Aspen Global Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aspen Global Antineoplastic Drugs Product and Service

    • Table Hoffmann-La Roche (Foundation Year, Company Profile and etc.)

    • Table Hoffmann-La Roche Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hoffmann-La Roche Antineoplastic Drugs Product and Service

    • Table Pfize (Foundation Year, Company Profile and etc.)

    • Table Pfize Antineoplastic Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfize Antineoplastic Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US